Gilead Sciences, Inc.: Drug Recall
Recall #D-0005-2025 · 09/19/2024
Class I: Dangerous
Recall Details
- Recall Number
- D-0005-2025
- Classification
- Class I
- Product Type
- Drug
- Recalling Firm
- Gilead Sciences, Inc.
- Status
- Terminated
- Date Initiated
- 09/19/2024
- Location
- Foster City, CA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 105,000 vials
Reason for Recall
Presence of Particulate Matter: Presence of glass particle.
Product Description
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
Distribution Pattern
Nationwide in the U.S.A.
Other Recalls by Gilead Sciences, Inc.
- Class I: Dangerous 12/03/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.